About Ilya Pharma
Ilya Pharma is a company based in Uppsala (Sweden) founded in 2016 by Mia Phillipson and Stefan Roos. Ilya Pharma has raised $4.02 million across 6 funding rounds from investors including EIT Health, European Union and EIC Fund. Ilya Pharma offers products and services including ILP100-Topical and ILP100-Oral.
- Headquarter Uppsala, Sweden
- Founders Mia Phillipson, Stefan Roos
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ilya Pharma Ab
-
Annual Revenue
$1.12 M (USD)433as on Dec 31, 2021
-
Net Profit
-$6.78 M (USD)-24as on Dec 31, 2021
-
EBITDA
-$6.78 M (USD)-24as on Dec 31, 2021
-
Total Equity Funding
$4.02 M (USD)
in 6 rounds
-
Latest Funding Round
$1.6 M (USD), Grant
Oct 01, 2020
-
Investors
EIT Health
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ilya Pharma
Ilya Pharma offers a comprehensive portfolio of products and services, including ILP100-Topical and ILP100-Oral.
A therapy is utilized for healing wounds in immunocompromised patients by employing genetically modified bacteria.
A treatment is applied for colitis in cancer patients through the use of live bacteria as local bioreactors.
Funding Insights of Ilya Pharma
Ilya Pharma has successfully raised a total of $4.02M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.6 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ilya Pharma
Ilya Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Health, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Ilya Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ilya Pharma
Investment portfolio details for Ilya Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ilya Pharma
Detailed financials for Ilya Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ilya Pharma Comparisons
Peer comparison for Ilya Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ilya Pharma
Detailed competitors of Ilya Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ilya Pharma
Complete news archive for Ilya Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ilya Pharma
Ilya Pharma was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Ilya Pharma is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
Ilya Pharma is a funded company, having raised a total of $4.02M across 6 funding rounds to date.
Annual revenue of Ilya Pharma is $1.12M as on Dec 31, 2021.
Ilya Pharma, a biopharma company, was founded in 2016 in Uppsala, Sweden. Biological drugs for acute and chronic wounds, including those in diabetic patients, are developed using human therapeutic proteins delivered by living lactic acid bacteria. The formulation is stored freeze-dried and revived with water prior to use. Focus is placed on skin and mucosa indications within the therapeutics sector.
Ilya Pharma offers ILP100-Topical and ILP100-Oral.
Ilya Pharma has 4 investors. Key investors include EIT Health, European Union, EIC Fund, and Professionell Ägarstyrning.